Oncolytic Virotherapy to Enhance PReoperative IMmunotherapy Efficacy in Patients With Proficient Mismatch Repair (pMMR) Rectal Cancer

计划入组 20 人 · 首次发布于 2026 年 7 月 7 日

Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma.

计划入组 53 人 · 首次发布于 2020 年 7 月 23 日

- IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases

计划入组 140 人 · 首次发布于 2025 年 3 月 4 日

MASH(Repair)

LGR6 modulators (wound repair)

CDP LNP-mRNA(Repair)

Proficient Rx LP

United States

Tissue Repair Ltd

Phoenix Tissue Repair, Inc.

United States

FDA Grants Fast Track Designation to NG-350A for Mismatch Repair-Proficient Locally Advanced Rectal Cancer

Lenvatinib-Pembrolizumab Combo Misses Survival Endpoints in Endometrial Cancer Trial

Optimizing Neoadjuvant Immunotherapy Strategies in Colorectal Cancer